1. Home
  2. VFF vs IPHA Comparison

VFF vs IPHA Comparison

Compare VFF & IPHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Village Farms International Inc.

VFF

Village Farms International Inc.

HOLD

Current Price

$1.99

Market Cap

230.2M

Sector

N/A

ML Signal

HOLD

Logo Innate Pharma S.A. ADS

IPHA

Innate Pharma S.A. ADS

HOLD

Current Price

$1.83

Market Cap

189.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VFF
IPHA
Founded
1989
1999
Country
United States
France
Employees
N/A
163
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
230.2M
189.5M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
VFF
IPHA
Price
$1.99
$1.83
Analyst Decision
Buy
Strong Buy
Analyst Count
1
4
Target Price
N/A
$5.75
AVG Volume (30 Days)
1.1M
9.0K
Earning Date
05-11-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
184.38
N/A
EPS
0.02
N/A
Revenue
$215,937,000.00
N/A
Revenue This Year
$12.19
$180.36
Revenue Next Year
$15.82
N/A
P/E Ratio
$99.50
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.27
$1.18
52 Week High
$4.99
$2.63

Technical Indicators

Market Signals
Indicator
VFF
IPHA
Relative Strength Index (RSI) 42.53 49.12
Support Level $1.81 $1.70
Resistance Level $2.10 $1.80
Average True Range (ATR) 0.10 0.09
MACD 0.03 -0.00
Stochastic Oscillator 61.02 16.63

Price Performance

Historical Comparison
VFF
IPHA

About VFF Village Farms International Inc.

Village Farms International Inc owns and operates intensive agricultural greenhouse facilities in British Columbia and Texas, where it produces, markets and sells tomatoes, bell peppers and cucumbers. Its wholly owned subsidiary, Pure Sunfarms, is a vertically integrated licensed producer and supplier of cannabis products sold to other licensed providers and provincial governments across Canada and internationally. The Company's wholly owned subsidiary, Balanced Health, develops and sells, cannabidiol (CBD) based products including ingestible, edible and topical applications. The operating segments of the Company are VF Fresh (Produce), Cannabis Canada, Cannabis U.S., Clean Energy, and Cannabis - Netherlands. The company makes majority of its revenue from the Cannabis Canada segment.

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. The company's approach includes therapeutic modalities such as monoclonal antibodies, multispecific NK cell engagers through its ANKET platform, and antibody-drug conjugates (ADC). Its portfolio includes lacutamab, which is being studied for cutaneous T-cell lymphomas and peripheral T-cell lymphomas, and monalizumab, which is being developed in collaboration with AstraZeneca for non-small cell lung cancer. The company's revenue mainly consists of revenues from collaboration and licensing agreements and government financing for research expenditure in the form of research tax credits, as well as other grants.

Share on Social Networks: